Proteolysis Targeting Chimera
Posts Tagged ‘monoclonal antibodies (mAbs)’
Can Proteins be Modified to Fight Diseases and Cancer?
Posted by Michael A. S. Guth on January 4th, 2024
Posted in Regulatory Medical Writing 
Tags: Disease-Causing Proteins, monoclonal antibodies (mAbs), NF-κB, PROTAC, Proteolysis Targeting Chimera, Proteolysis Targeting Chimerics, small molecule inhibitors (SMIs), transcription factors, Ubiquitin-Proteasome System (UPS) 
Comments Off on Can Proteins be Modified to Fight Diseases and Cancer?